Company profile for Virax Biolabs

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases. The company is a revenue generating group operating since 2013 whose primary business is the proprietary development and global distribution of in vitro diagnostic (IVD) test kits. Virax Immune is our flagship product focused on the global provision of T-Cell tests, which accurately and effectively pred...
Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases. The company is a revenue generating group operating since 2013 whose primary business is the proprietary development and global distribution of in vitro diagnostic (IVD) test kits. Virax Immune is our flagship product focused on the global provision of T-Cell tests, which accurately and effectively predict an individual's immune response to significant viral threats. This life impacting product offering is scheduled to be available for distribution Q3 2022. Virax also offers a range of In Vitro Diagnostic device.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
20 North Audley Street London W1K 6LX
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/virax-biolabs-group-limited-announces-closing-of-5-million-private-placement-302633534.html

PR NEWSWIRE
04 Dec 2025

https://www.prnewswire.com/news-releases/virax-biolabs-group-limited-announces-5-million-private-placement-302632166.html

PR NEWSWIRE
04 Dec 2025

https://www.prnewswire.com/news-releases/virax-biolabs-ceo-james-foster-outlines-clinical-progress-and-2026-priorities-in-latest-annual-letter-to-shareholders-302631258.html

PR NEWSWIRE
03 Dec 2025

https://www.prnewswire.com/news-releases/virax-biolabs-partners-with-emory-university-on-viraximmune-clinical-studies-readies-for-fda-pre-submission-meeting-in-early-september-302537678.html

PR NEWSWIRE
26 Aug 2025

https://www.prnewswire.com/news-releases/virax-biolabs-appoints-iain-miller-phd-as-independent-director-to-accelerate-commercial-strategy-302515923.html

PR NEWSWIRE
29 Jul 2025

https://www.prnewswire.com/news-releases/virax-biolabs-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency-302505259.html

PR NEWSWIRE
18 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty